Logotype for Collegium Pharmaceutical Inc

Collegium Pharmaceutical (COLL) investor relations material

Collegium Pharmaceutical Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Collegium Pharmaceutical Inc
Q3 2025 earnings summary6 Nov, 2025

Executive summary

  • Achieved record quarterly net revenue of $209.4 million, up 31% year-over-year, and record adjusted EBITDA of $133 million, up 27% year-over-year, driven by strong performance from Jornay PM and the pain portfolio.

  • Net income for Q3 2025 was $31.5 million, up from $9.3 million in Q3 2024, reflecting the Ironshore acquisition and product revenue growth.

  • Raised 2025 financial guidance based on continued strong performance and confidence in portfolio durability.

  • Ended Q3 2025 with $285.9 million in cash, cash equivalents, and marketable securities.

  • Strategic priorities include driving growth for Jornay, maximizing the pain portfolio's durability, and deploying capital for shareholder value.

Financial highlights

  • Q3 2025 net revenue: $209.4 million (+31% YoY); adjusted EBITDA: $133 million (+27% YoY); gross profit: $129.2 million; gross margin: 61.7%.

  • GAAP net income: $31.5 million ($1.00 basic EPS, $0.84 diluted EPS); adjusted net income: $87.3 million ($2.25 adjusted EPS).

  • Operating income for Q3 2025 was $62.1 million, up from $34.8 million in Q3 2024.

  • Cash, cash equivalents, and marketable securities totaled $285.9 million as of September 30, 2025.

  • Generated $78.4 million in cash from operations during Q3 2025.

Outlook and guidance

  • 2025 total product revenue expected at $775–$785 million (+24% YoY), with Jornay revenue projected at $145–$150 million (+46% from 2024 pro forma).

  • Adjusted EBITDA guidance raised to $460–$470 million (+16% YoY); adjusted operating expenses expected at $235–$240 million.

  • Gross-to-net for Jornay expected in the mid-60% range for full year.

  • Management expects current cash and expected operating cash flows to fund operations, debt service, and capital expenditures for the foreseeable future.

  • Pain portfolio expected to remain a durable financial base; no major payer changes anticipated for 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Collegium Pharmaceutical earnings date

Logotype for Collegium Pharmaceutical Inc
Jefferies London Healthcare Conference 202519 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Collegium Pharmaceutical earnings date

Logotype for Collegium Pharmaceutical Inc
Jefferies London Healthcare Conference 202519 Nov, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage